Consumer News Novo Nordisk Is Ending Insulin Product Sales In The U S Three Senators Are Not Happy

Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill, as the firm races to claw back lost ... Read More

Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ... Read More

Novo Nordisk to cut prices of several insulins

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and ... Read More

Novo Nordisk CEO Says White House Pricing Deal Aims to Expand Wegovy Access

Novo Nordisk (NYSE:NOV) chief executive Mike Doustdar said Monday that the company’s newly announced agreement with the White House—aimed at lowering the cost of its leading weight-loss medicines—is ... Read More

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.

Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know. Sluggish growth for Novo Nordisk's GLP-1 drugs caused the company to again reduce its ... Read More

Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S.

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to make Wegovy available on its platform. The discussions are about both ... Read More